Neil Kumar
Chief Executive Officer, Director · BridgeBio Pharma, Inc.
- 2024
- Sep 21, 2026
- 29
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Neil Kumar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer E. Cook - $21.92M in BBIO purchases and sales in the last 12 months
- Frank McCormick - $13.31M in BBIO purchases and sales in the last 12 months
- Andrew Lo - $6.32M in BBIO purchases and sales in the last 12 months
- Andrea Ellis - $5.65M in BBIO purchases and sales in the last 12 months
- Hannah Valantine - $4.37M in BBIO purchases and sales in the last 12 months
- Ronald J. Daniels - $3.89M in BBIO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Neil Kumar?
Neil Kumar is a corporate insider, tracked as Chief Executive Officer, Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha holds 29 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Neil Kumar submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Neil Kumar been buying or selling stock?
Recorded transactions: 0 open-market purchases and 124 open-market sales ($62.73M) across all tracked filings.
